News
What we've been up to.
Milestones, certifications, research and where we're headed next.
Milestones, certifications, research and where we're headed next.
ATI — Advanced Medical Technologies Ltd is looking forward to raise a 5 Million USD investment in order to finish development, certification, and begin marketing and sales of FIM 2nd generation — and to start development of NIT 1st generation.
Ms. Anna Wu, Owner and CEO of Longing Health Ltd, joins ATI. A very warm welcome and lots of success to her and Longing Health.
Tom Gordy, President and CEO of TAGG, joins ATI as a partner. Lots of success to Tom and TAGG.
Prof. David Varsano, M.D., world-renowned in his field, joins ATI's management team as Chief Medical Officer.
ATI attends and presents at the China-Israel Summit Conference.
ATI and India's Remidio Innovative Solutions begin a new cooperation to integrate FIM technology into Remidio's Mobile Fundus Camera.
ATI finishes design and manufacturing of the FIM Second Generation first prototype, planned and designed entirely in-house.
ATI begins development of the new 2nd generation FIM device, with new and more advanced features.
ATI renews CE Marking of Conformity and the ISO 13485:2003 certificate.
ATI completes large-scale clinical research at Tel Aviv Sourasky Medical Center (Ichilov), covering a range of diagnostic procedures and patients within the Ophthalmology Department.
ATI receives Israel Ministry of Health AMR (Medical Devices) Marking of Conformity for FIM.
FIM, the world's first pupil dilation device, is introduced at the Israel Eye Microsurgery Conference in Eilat — attracting much attention from attendees and fellow exhibitors.
ATI receives CE Marking of Conformity (Dekra Certification B.V.) and the ISO 13485:2003 certificate for FIM.
